Monoclonal Mouse anti‑Human SPTA1 / Alpha Spectrin Antibody (clone AF10, Concentrated, IHC, WB) LS‑C202546
Monoclonal Mouse anti‑Human SPTA1 / Alpha Spectrin Antibody (clone AF10, Concentrated, IHC, WB) LS‑C202546
Antibody:
SPTA1 / Alpha Spectrin Mouse anti-Human Monoclonal (Concentrated) (AF10) Antibody
Application:
IHC, IHC-Fr, ICC, WB, IP
Format:
Unconjugated, Concentrated
Overview
Antibody:
SPTA1 / Alpha Spectrin Mouse anti-Human Monoclonal (Concentrated) (AF10) Antibody
Application:
IHC, IHC-Fr, ICC, WB, IP
Format:
Unconjugated, Concentrated
Specifications
Description
Alpha Spectrin antibody LS-C202546 is an unconjugated mouse monoclonal antibody to human Alpha Spectrin (SPTA1). Validated for ICC, IHC, IP and WB.
Target
Human SPTA1 / Alpha Spectrin
Synonyms
SPTA1 | EL2 | Erythroid alpha-spectrin | HS3 | Alpha-I spectrin | HPP | SPH3 | SPTA
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Unconjugated
Modifications
Concentrated
Applications
- IHC
- IHC - Frozen
- ICC
- Western blot
- Immunoprecipitation
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Presentation
PBS, 1.0% BSA, 0.1% sodium azide
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About SPTA1 / Alpha Spectrin
Featured Products
Species:
Human, Mouse
Applications:
IHC, Western blot, ELISA
Reactivity:
Human
Range:
0.312-20 ng/ml
Species:
Human, Rat
Applications:
Western blot
Reactivity:
Human
Range:
0.23-15 ng/ml
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, ELISA
Species:
Human
Applications:
IHC - Paraffin, Western blot
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/26/2024